Skip to main content
. 2020 Jan 15;10:1344. doi: 10.3389/fneur.2019.01344

Table 5.

Comparison of the Rivermead Mobility Index at baseline and after therapy.

Outcome measure Experimental group χ2a pa Control group χ2a pa χ2b pb
RMI 1 Baseline 1 ± 0(1−1) 2.6 n.s. 1 ± 0(1−1) 1 n.s. 0 n.s.
Post 1 ± 0(1−1) 1 ± 0(1−1) 0 n.s.
RMI 2 Baseline 0 ± 1(0−1) 12 0.0005 1 ± 1(0−1) 6 0.01 7.3 0.006
Post 1 ± 0(1−1) 1 ± 0(1−1) 0 n.s.
RMI 3 Baseline 1 ± 0(1−1) 2 n.s. 1 ± 0(1−1) 2 n.s. 0 n.s.
Post 1 ± 0(1−1) 1 ± 0(1−1) 0 n.s.
RMI 4 Baseline 0 ± 0(0−0) 8 0.004 1 ± 1(0−1) 5 0.02 7 0.006
Post 1 ± 1(0−1) 1 ± 0(1−1) 0 n.s.
RMI 5 Baseline 0 ± 0(0−0) 0.6 n.s. 1 ± 1(0−1) 4 0.04 5.8 0.01
Post 0 ± 1(0−1) 1 ± 0(1−1) 0 n.s.
RMI 6 Baseline 0 ± 1(0−1) 8 0.004 1 ± 1(0−1) 4 0.04 4.3 0.03
Post 1 ± 1(0−1) 1 ± 0(1−1) 0 n.s.
RMI 7 Baseline 0 ± 0(0−0) 4.5 0.03 1 ± 1(0−1) 3 n.s. 11.8 0.0006
Post 0 ± 1(0−1) 1 ± 1(0−1) 0 n.s.
RMI 8 Baseline 0 ± 0(0−0) 4.5 0.03 1 ± 1(0−1) 0 n.s. 7.4 0.006
Post 0 ± 1(0−1) 1 ± 1(0−1) 0.8 n.s.
RMI 9 Baseline 0 ± 0(0−0) 4 0.04 0 ± 1(0−1) 3 n.s. 3.4 n.s.
Post 0 ± 1(0−1) 1 ± 1(0−1) 2.2 n.s.
RMI 10 Baseline 0 ± 0(0−0) 1.8 n.s. 0 ± 1(0−1) 2 n.s. 10.9 0.0009
Post 0 ± 0(0−0) 1 ± 1(0−1) 7.4 0.006
RMI 11 Baseline 0 ± 0(0−0) 8 0.004 1 ± 1(0−1) 1 n.s. 12.7 0.0004
Post 0 ± 1(0−1) 1 ± 1(0−1) 1.4 n.s.
RMI 12 Baseline 0 ± 0(0−0) 3 n.s. 1 ± 1(0−1) 0 n.s. 16 0.0001
Post 0 ± 0(0−0) 1 ± 1(0−1) 7.8 0.005
RMI 13 Baseline 0 ± 0(0−0) 3 n.s. 0 ± 1(0−1) 5 0.02 2.2 n.s.
Post 0 ± 1(0−1) 1 ± 1(0−1) 4.4 0.03
RMI 14 Baseline 0 ± 0(0−0) 3 n.s. 0 ± 1(0−1) 0 n.s. 4.9 0.02
Post 0 ± 1(0−1) 0 ± 1(0−1) 2.1 n.s.
RMI 15 Baseline 0 ± 0(0−0) 1 n.s. 0 ± 0(0−0) 0 n.s. 0 n.s.
Post 0 ± 0(0−0) 0 ± 0(0−0) 0 n.s.
RMI total Baseline 3 ± 5(1−6) 17 0.0003 10 ± 12(2−14) 0.6 n.s. 3.2 n.s.
Post 6 ± 7(3−10) 13 ± 8(6−14) 1.4 n.s.

pa–p-value between baseline and post-therapy within each group.

pb–p-value between study groups.

χ2a–chi-square test value within each group.

χ2b–chi-square test value between study groups.

n.s.—non-significant.

Values are expressed as median ± quantile range (lower quantile–upper quantile).

Statistically significant results are marked in bold.

RMI 1—turning from the back to the side without help.

RMI 2—independent transition from lying in bed to sitting on the edge of the bed.

RMI 3—sitting on the edge of the bed alone, without holding on to anything for 10 s.

RMI 4—getting up from the chair in <15 s (using a hand or help if necessary) and the ability to maintain a standing position for the next 15 s.

RMI 5—observation of the patient standing alone, without help for 10 s.

RMI 6—moving from bed to chair and back without any help.

RMI 7—10-m walking distance, with an orthopedic aid if necessary, but without anyone's help.

RMI 8—independently climbing up a stair (step), without help.

RMI 9—walking outside, on pavement.

RMI 10—independent walking inside, without a splint, stabilizer, or anyone's help.

RMI 11—walking 5 m to lift something that fell to the floor and return.

RMI 12—walking on uneven ground (grass, gravel, earth, snow, and ice) without help.

RMI 13—independently getting into the shower or into the bathtub and bathing without supervision.

RMI 14—going up and down four stairs without handrails, but using an aid if necessary.

RMI 15—running 10 m in 4 s without limping; fast gait is acceptable.

RMI total—total score.